The Incretin Space
A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretins in medicine
Written by
The Incretin Space
Archive
GLP-1
+5
Oct 5, 2026
•
16 min read
EASD 2026: The weight equation is solved?
Retatrutide and EloraTirz provide shock and awe at EASD
GLP-1
+2
Sep 14, 2026
•
15 min read
(Insulin) Sensitivity Training
An intro guide to a misunderstood metric of diabetic and cardiometabolic risk
Glucagon
+2
Aug 31, 2026
•
10 min read
The Clue is in Ketones
Retatrutide's metabolomics data reveals hints about weight loss differences between diabetics and non-diabetics
GLP-1
+3
Jul 28, 2026
•
7 min read
Retatrutide revolution continues
Weight loss remains the star of the show, but cardiovascular data was underpowered
